Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenclorothen Tablets in Mild to Moderate Alzheimer's Disease
CTR20130335Phase 2Completed
- Sponsor
- Yunnan Xipurui Bioengineering
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fencrolone in Alzheimer's disease (AD), sponsored by Yunnan Xipurui Bioengineering. Started Jan 2014; status: completed.
02
Drugs
fencrolone
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on CTR20130335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130335.